Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis

Xiaoli Zheng(Zhengzhou University), Hong Ge(Zhengzhou University), Yang Yang(Zhengzhou University), Xiaohui Wang(Zhengzhou University), Ke Ye(Zhengzhou University), Chengcheng Fan(Zhejiang University), Yanan Sun(Zhengzhou University), Ruidi Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Thoracic Cancer
February 2, 2021
10.1111/1759-7714.13768
Cited by 5

Related Papers

Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer
|Cell Death and Disease|2020|109
Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)
|Oncotarget|2017|46
<p>Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities</p>
|OncoTargets and Therapy|2019|39
IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
|Frontiers in Oncology|2020|21
Lipid metabolism analysis in esophageal cancer and associated drug discovery
|Journal of Pharmaceutical Analysis|2023|20